Forgot Password?

If you are Corporate user, please
click here
If you have a user ID already and cannot login, contact Customer Support
You can begin the registration process by clicking here

Consumer Health Care // Diabetes Cardiovascular // General Medicine & Emerging Market // Global Health // Sanofi Genzyme // Sanofi Pasteur

Innovative research is important to advancing knowledge about our products, core diseases, and therapeutic areas of interest with the goal of advancing patient care. With an electronic process that has been established, we invite qualified and experienced researchers worldwide interested in pursuing their own research concepts to submit their applications through this Investigator Sponsored Study (ISS)* Portal for Sanofi to review and potentially support.

Note that this portal is not to be used for Grants, Donations, Charitable Contributions or collaborative study requests. Please register and/or log in to Visiontracker** to view our current Areas of Interest.

The intent of this tool is not to collect adverse events either actual or potential that should be reported through the normal channel in place in your country.

If you cannot create your request in Visiontracker, please contact and clearly indicate:

  • Your contact information and your preferred method of contact
  • Your country of origin
  • Product to be studied or therapeutic area of interest to be studied in your ISS (please register and/or log in to view our Areas of interest)
  • A very brief description of your idea

This information will allow us to forward your inquiry to the appropriate medical affairs personnel in your country or region.

Important Note on Disclosure

Sanofi is committed to transparency in its interactions with healthcare professionals and health care organizations/institutions consistent with applicable laws and/or codes of practice applicable to the pharmaceutical industry.

*Investigator Sponsored Study (ISS) may also be referred to as Investigator Sponsored Trial (IST) or Expert Initiated Research (EIR)
**:Envision is the Platform provider

Website last update: Jul 2017